OHSU in the news

Ixekizumab improves outcomes of ankylosing spondylitis

The Rheumatologist November 05, 2018
Clinical trial summary results, Atul Deodhar, M.D., says “If ixekizumab is approved for the treatment of ankylosing spondylitis, it will would give physicians another option for patients, which is necessary.

OHSU and UO joint research teams report progress, plans

Around the O November 02, 2018
In October, researchers from the University of Oregon and OHSU convened to discuss collaborative study. Danny Jacobs, M.D., M.P.H. F.A.C.S., says, “ Breakthroughs will occur now more than ever when researchers from seemingly disparate fields get together and talk about the way forward. That’s where the magic happens.”

OHSU's treating more patients. Here's why.

Portland Business Journal November 02, 2018
Highlights of OHSU’s Mission Control command center, noting that “since Mission Control debuted, OHSU accepted 554 more transfer patients.”

The 7 craziest ways CRISPR is being used right now

Medium November 01, 2018
Shoukhrat Mitalipov, Ph.D., and the Center for Embryonic Cell and Gene Therapy are included in a Medium article summarizing “The 7 Craziest Ways CRISPR is Being Used Right Now.”
See more stories